gastrointestinal neuroendocrine tumor (Cancer)
Information
- Disease name
- gastrointestinal neuroendocrine tumor
- Disease ID
- DOID:0050626
- Description
- "A gastrointestinal system cancer that has_material_basis_in neuroendocrine cells." [url:http\://en.wikipedia.org/wiki/Neuroendocrine_tumor, url:http\://www.cancer.gov/dictionary?CdrID=44904]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05196087 | Recruiting | Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) | July 20, 2022 | June 2026 | |
NCT05988918 | Recruiting | Phase 2 | Multicenter Trial of ESK981 in Patients With Select Solid Tumors | April 19, 2024 | April 2029 |
NCT05997056 | Recruiting | Phase 2 | Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors | November 7, 2023 | December 8, 2025 |
NCT03963193 | Unknown status | Phase 2 | Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type | June 1, 2019 | June 1, 2021 |
- Disase is a (Disease Ontology)
- DOID:3119
- Exact Synonym (Disease Ontology)
- gastrointestinal neuroendocrine tumour
- Exact Synonym (Disease Ontology)
- malignant gastrointestinal neuroendocrine tumor
- Exact Synonym (Disease Ontology)
- malignant gastrointestinal neuroendocrine tumour